ACRS has been granted a new patent
Mar 05, 2025, 11:36 PM
-18.75%
What does ACRS do
Aclaris Therapeutics, a biopharmaceutical company based in Wayne, Pennsylvania, focuses on developing novel drugs for dermatology and immunology, with key candidates including ATI-1777 and Zunsemetinib. Founded in 2015, it employs 91 staff and utilizes its KINect platform for drug discovery.
ACRS filed a patent for "crystalline polymorph form a of a jak inhibitor and methods for its preparation" on Wed, August 16, 2023.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.